Opko Health (OPK)

• Market cap: $1.2B
• 1 day: -2.81%
• 5 days: -7.98%
• 1 month: 4.22%
• 3 months: 8.81%
• 6 months: 10.19%
• Year to date: 19.31%
• 1 year: 88.19%
• 5 years: -8.95%
• 10 years: -88.17%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.

Employees: 3,930

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

14% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 29

10% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 60

2.0% more ownership

Funds ownership: 26.86% [Q3] → 28.86% (+2.0%) [Q4]

3% more capital invested

Capital invested by funds: $280M [Q3] → $289M (+$8.95M) [Q4]

1% less funds holding

Funds holding: 232 [Q3] → 229 (-3) [Q4]

45% less call options, than puts

Call options by funds: $9.74M | Put options by funds: $17.7M

100% less funds holding in top 10

Funds holding in top 10: 1 [Q3] → 0 (-1) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $2.25 30% upside
• Avg. target: $2.63 52% upside
• High target: $3 73% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Yi Chen 36% 1-year accuracy 58 / 162 met price target	73% upside $3	Buy Reiterated	12 Mar 2025
Barrington Research Michael Petusky 38% 1-year accuracy 28 / 74 met price target	30% upside $2.25	Outperform Maintained	12 Mar 2025